1. What Do the Transcriptome and Proteome of Menstrual Blood-Derived Mesenchymal Stem Cells Tell Us about Endometriosis?
   Letícia B. C. Penariol et al, 2022, International Journal of Molecular Sciences CrossRef
2. Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy
   Xintao Gao et al, 2023, Journal of Medicinal Chemistry CrossRef
3. Interplay Between mTOR and Hippo Signaling in the Ovary: Clinical Choice Guidance Between Different Gonadotropin Preparations for Better IVF
   Kyriaki Papageorgiou et al, 2021, Frontiers in Endocrinology CrossRef
4. Preclinical Studies on the Effect of Rucaparib in Ovarian Cancer: Impact of BRCA2 Status
   Sayeh Saravi et al, 2021, Cells CrossRef
5. The Role of mTOR and eIF Signaling in Benign Endometrial Diseases
   Tatiana S. Driva et al, 2022, International Journal of Molecular Sciences CrossRef
6. Expression of mTOR in normal and pathological conditions
   A Marques-Ramos et al, 2023, Molecular Cancer CrossRef
7. Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer
   Juhi Kumar et al, 2019, Frontiers in Oncology CrossRef
8. Ribosome Biogenesis Serves as a Therapeutic Target for Treating Endometriosis and the Associated Complications
   Cherry Yin-Yi Chang et al, 2022, Biomedicines CrossRef